Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Oncology|January 1, 1976
Effect of trimethylcolchicinic acid methyl ether d-tartrate (TMCA) on Hodgkin's and non-Hodgkin's lymphomaD C Stolinsky, E M Jacobs, L E Irwin, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1983
The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiationB F Danoff, R L Goodman, J H Glick, et al.
Cancer|April 15, 1987
Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. An RTOG study of 114 advanced stage tumorsJ D Crissman, T F Pajak, R J Zarbo, et al.
Cancer Treatment Reports|September 1, 1976
Phase I alternate-day dose study of chromomycin A3R D Reynolds, J I Fisher, P A Jensen, et al.
Oncology|January 1, 1976
Treatment of advanced lymphomas with bleomycin (NSC-125066)W J Durkin, R P Pugh, J Solomon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group studyM al-Sarraf, T F Pajak, J S Cooper, et al.
American Journal of Clinical Oncology|August 1, 1991
Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08J D Cox, T F Pajak, A Herskovic, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07R W Byhardt, T F Pajak, B Emami, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocolR W Byhardt, L Martin, T F Pajak, et al.
Cancer|November 1, 1981
Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group BF Cavalli, W F Jungi, N I Nissen, et al.
Pageof 15